The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future Challenges

Vascular disorders are complex diseases with high morbidity and mortality. Among them, the dilated macrovascular diseases (MVD), such as aortic aneurysm and aortic dissection, have presented a huge threat to human health. The pathogenesis of vascular diseases is mostly associated with property alter...

Full description

Saved in:
Bibliographic Details
Main Authors: Guang-Yin Peng, Yang Lin, Jing-Jing Li, Ying Wang, Hao-Yue Huang, Zhen-Ya Shen
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2019/9613258
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849411507352240128
author Guang-Yin Peng
Yang Lin
Jing-Jing Li
Ying Wang
Hao-Yue Huang
Zhen-Ya Shen
author_facet Guang-Yin Peng
Yang Lin
Jing-Jing Li
Ying Wang
Hao-Yue Huang
Zhen-Ya Shen
author_sort Guang-Yin Peng
collection DOAJ
description Vascular disorders are complex diseases with high morbidity and mortality. Among them, the dilated macrovascular diseases (MVD), such as aortic aneurysm and aortic dissection, have presented a huge threat to human health. The pathogenesis of vascular diseases is mostly associated with property alteration of vascular endothelial cells (VECs) and vascular smooth muscle cells (VSMCs). Studies have confirmed that induced pluripotent stem cells (iPSCs) can be proliferated and differentiated into other somatic cells, such as VECs and VSMCs. And patient-specific cells could provide detailed human-associated information in regard to pathogenesis or drug responses. In addition, differentiated ECs from iPSC have been widely used in disease modeling as a cell therapy. In this review, we mainly discussed the application of hiPSCs in investigating the pathological mechanism of different inherited vascular diseases and provide a comprehensive understanding of hiPSCs in the field of clinical diagnosis and gene therapy.
format Article
id doaj-art-5dafd3e8afed451fbd8e1585337d6fe2
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-5dafd3e8afed451fbd8e1585337d6fe22025-08-20T03:34:45ZengWileyStem Cells International1687-966X1687-96782019-01-01201910.1155/2019/96132589613258The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future ChallengesGuang-Yin Peng0Yang Lin1Jing-Jing Li2Ying Wang3Hao-Yue Huang4Zhen-Ya Shen5Department of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu, ChinaDepartment of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Soochow University, Suzhou, Jiangsu, ChinaVascular disorders are complex diseases with high morbidity and mortality. Among them, the dilated macrovascular diseases (MVD), such as aortic aneurysm and aortic dissection, have presented a huge threat to human health. The pathogenesis of vascular diseases is mostly associated with property alteration of vascular endothelial cells (VECs) and vascular smooth muscle cells (VSMCs). Studies have confirmed that induced pluripotent stem cells (iPSCs) can be proliferated and differentiated into other somatic cells, such as VECs and VSMCs. And patient-specific cells could provide detailed human-associated information in regard to pathogenesis or drug responses. In addition, differentiated ECs from iPSC have been widely used in disease modeling as a cell therapy. In this review, we mainly discussed the application of hiPSCs in investigating the pathological mechanism of different inherited vascular diseases and provide a comprehensive understanding of hiPSCs in the field of clinical diagnosis and gene therapy.http://dx.doi.org/10.1155/2019/9613258
spellingShingle Guang-Yin Peng
Yang Lin
Jing-Jing Li
Ying Wang
Hao-Yue Huang
Zhen-Ya Shen
The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future Challenges
Stem Cells International
title The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future Challenges
title_full The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future Challenges
title_fullStr The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future Challenges
title_full_unstemmed The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future Challenges
title_short The Application of Induced Pluripotent Stem Cells in Pathogenesis Study and Gene Therapy for Vascular Disorders: Current Progress and Future Challenges
title_sort application of induced pluripotent stem cells in pathogenesis study and gene therapy for vascular disorders current progress and future challenges
url http://dx.doi.org/10.1155/2019/9613258
work_keys_str_mv AT guangyinpeng theapplicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT yanglin theapplicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT jingjingli theapplicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT yingwang theapplicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT haoyuehuang theapplicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT zhenyashen theapplicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT guangyinpeng applicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT yanglin applicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT jingjingli applicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT yingwang applicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT haoyuehuang applicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges
AT zhenyashen applicationofinducedpluripotentstemcellsinpathogenesisstudyandgenetherapyforvasculardisorderscurrentprogressandfuturechallenges